MONTREAL, QUEBEC -- (MARKET WIRE) -- April 17, 2007 -- MethylGene Inc. (TSX: MYG) disclosed biomarker data for its histone deacetylase (HDAC) inhibitor, MGCD0103, at the American Association for Cancer Research (AACR) Annual Meeting in Los Angeles, California from April 14-18, 2007.
